Incorporation of antitubercular drug isoniazid in pharmaceutically accepted microemulsion: Effect on microstructure and physical parameters

被引:48
作者
Mehta, S. K. [1 ,2 ]
Kaur, Gurpreet [1 ,2 ]
Bhasin, K. K. [1 ,2 ]
机构
[1] Punjab Univ, Dept Chem, Chandigarh 160014, India
[2] Punjab Univ, Ctr Adv Studies, Chandigarh 160014, India
关键词
controlled release; drug delivery potential; isoniazid; microemulsion; solubility; stability; structural changes;
D O I
10.1007/s11095-007-9355-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of present study is to formulate microemulsion composed of oleic acid, phosphate buffer, Tween 80, ethanol and to investigate its potential as drug delivery system for an antitubercular drug isoniazid. Materials and Methods. The pseudo-ternary phase diagram (Gibbs Triangle) was delineated at constant surfactant/co-surfactant ratio (Km 0.55). Changes in the microstructure were established using conductivity (sigma), viscosity (eta), surface tension (gamma) and density measurements. Dissolution studies and particle size analysis were carried out to understand the release of isoniazid from the microemulsion formulation. Further, partitioning studies and spectroscopic analysis (FT-IR and H-1 NMR) was performed to evaluate the location of drug in the colloidal formulation. Results. Physico-chemical analysis of microemulsion system showed the occurrence of structural changes from water-in-oil to oil-in-water microemulsion. It has been observed that the microemulsion remained stable after the incorporation of isoniazid (in terms of optical texture, pH and phase separation). The changes in the microstructure of the microemulsion after incorporation of drug was analyzed on the basis of partition studies of isoniazid in microemulsion components and various parameters viz pH, sigma, eta,gamma. In addition, the particle size analysis indicates that the microemulsion changes into o/w emulsion at infinite dilution. The spectroscopic studies revealed that most of the drug molecules are present in the continuum region of an o/w microemulsion. Dissolution studies infer that a controlled release of drug is expected from o/w emulsion droplet. In the present system the release of isoniazid from microemulsion was found to be non-Fickian. Conclusion. The present Tween based microemulsion appears beneficial for the delivery of the isoniazid in terms of easy preparation, stability, low cost, sustained and controlled release of a highly water soluble drug.
引用
收藏
页码:227 / 236
页数:10
相关论文
共 49 条
[11]  
El-Laithy HM, 2003, AAPS PHARM SCI TECH, V4, P1, DOI [10.1208/pt040111, DOI 10.1208/PT040111]
[12]   In vitro skin permeation of estradiol from various proniosome formulations [J].
Fang, JY ;
Yu, SY ;
Wu, PC ;
Huang, YB ;
Tsai, YH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 215 (1-2) :91-99
[13]  
FLORENCE AT, PHYSIOCOCHEMICAL PRI
[14]   DYNAMIC PERCOLATION IN MICROEMULSIONS [J].
GREST, GS ;
WEBMAN, I ;
SAFRAN, SA ;
BUG, ALR .
PHYSICAL REVIEW A, 1986, 33 (04) :2842-2845
[15]   The release of cephanone in CTAB/n-C5H11OH/H2O system [J].
Guo, R ;
Qian, SH ;
Zhu, J ;
Qian, JH .
COLLOID AND POLYMER SCIENCE, 2006, 284 (05) :468-474
[16]   Microemulsion formulation for enhanced absorption of poorly soluble drugs - II. In vivo study [J].
Kawakami, K ;
Yoshikawa, T ;
Hayashi, T ;
Nishihara, Y ;
Masuda, K .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (1-2) :75-82
[17]  
Kibbe A.H., 2000, HDB PHARM EXCIPIENTS
[18]   Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery [J].
Kim, CK ;
Cho, YJ ;
Gao, ZG .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (1-2) :149-155
[19]   Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10:: formulation development and bioavailability assessment [J].
Kommuru, TR ;
Gurley, B ;
Khan, MA ;
Reddy, IK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) :233-246
[20]   Influence of a microemulsion vehicle on cutaneous bioequivalence of a lipophilic model drug assessed by microdialysis and pharmacodynamics [J].
Kreilgaard, M ;
Kemme, MJB ;
Burggraaf, J ;
Schoemaker, RC ;
Cohen, AF .
PHARMACEUTICAL RESEARCH, 2001, 18 (05) :593-599